Click Therapeutics raises $30 million in debt to advance commercialization of smoking cessation app Clickotine

By SharpBrains | December 4, 2020

Click Ther­a­peu­tics Secures $30M in Growth Cap­i­tal from K2 HealthVen­tures to Expand Oper­a­tions (press release): Click Ther­a­peu­tics, Inc. (“Click”), a leader in Dig­i­tal Ther­a­peu­tics™ solu­tions as pre­scrip­tion med­ical treat­ments, today announced $30 mil­lion in debt financ­ing from K2 HealthVen­tures (K2HV), a health­­care-focused spe­cial­ty finance com­pa­ny, to accel­er­ate com­mer­cial­iza­tion of its lead­ing smok­ing ces­sa­tion solu­tion, Clickotine™,…

Read More

Studies identify key ethical concerns raised by invasive and non-invasive neurotechnologies

By SharpBrains | November 23, 2020

Stud­ies out­line key eth­i­cal ques­tions sur­round­ing brain-com­put­er inter­face tech (NCSU release): Brain-com­put­er inter­face (BCI) tech­nolo­gies are no longer hypo­thet­i­cal, yet there are fun­da­men­tal aspects of the tech­nol­o­gy that remain unad­dressed by both ethi­cists and pol­i­­cy-mak­ers. Two new papers address these issues by out­lin­ing the out­stand­ing eth­i­cal issues, offer­ing guid­ance for address­ing those issues, and offering…

Read More

Tuesday April 28th, online: Explore strategies and tools to boost mental wellbeing during (and after) Covid-19

By SharpBrains | April 23, 2020

Heads-up about a very time­ly vir­tu­al event next week. When: Tues­day, April 28th, 9am — 6pm US Pacif­ic Time (San Fran­cis­co time zone) Where: Online What: Find Well­be­ing Dur­ing Covid19 — Dis­cov­er 200+ Free and Dis­count­ed Tools to help you find some relief and emerge even stronger How: Learn More and Reg­is­ter HERE Con­firmed Speak­ers include:

Read More

Fast Forward to 2040: How to prepare for the new era in brain enhancement that will change the way we think, work, and heal

By Tan Le | March 19, 2020

Decades from now when our aug­ment­ed brains have enhanced our cog­ni­tive func­tion and trans­formed near­ly every aspect of our lives, many of us will look back and won­der why we didn’t do more to pre­pare for these inevitable changes. Gov­ern­ment lead­ers may grap­ple with the run­away effects of AI and brain enhance­ment on geopol­i­tics. Companies…

Read More

Will digital therapeutics complement or replace stimulant medications to address inattention and “silent” cognitive issues?

By SharpBrains | January 29, 2020

___ Akili Inter­ac­tive: Dig­i­tal pedi­atric ADHD ther­a­peu­tic per­forms well with or with­out accom­pa­ny­ing stim­u­lant ther­a­py (Mobi­Health News): “Dig­i­tal ther­a­peu­tic com­pa­ny Akili Inter­ac­tive has announced the first results of an open-label, mul­ti­site pedi­atric ADHD tri­al pro­vid­ing some patients with the company’s video game-like treat­ment along­side a stim­u­lant med­ica­tion. Accord­ing to the com­pa­ny, both those who received…

Read More

Neurotech seen at CES 2020: BrainCo prosthetic hand, Urgonight, Alpha-Stim X, NIRSIT Lite, Muse S and FocusFit

By SharpBrains | January 22, 2020

___ Brain tech is here: These gad­gets from CES 2020 rely on your brain­waves to work (CNET): “The futur­is­tic promise of tech devices that use brain waves to improve sleep, anx­i­ety and con­cen­tra­tion — and even con­trol pros­thet­ic hands — may final­ly be com­ing to fruition, with a slew of new prod­ucts on dis­play at…

Read More